109 related articles for article (PubMed ID: 11343996)
1. Trans-urethral whole layer core biopsy for detection of residual tumor after neoadjuvant therapy in invasive bladder cancer.
Hoshi S; Ono K; Suzuki K; Ohyama C; Namima T; Orikasa S
Urol Oncol; 2001 May; 6(3):85-89. PubMed ID: 11343996
[TBL] [Abstract][Full Text] [Related]
2. [Trans-urethral whole layer core biopsy of invasive bladder tumor].
Hoshi S; Orikasa S; Yoshikawa K; Saitoh S; Ohyama C; Satoh M; Kawamura S; Suzuki K
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):715-21. PubMed ID: 8022134
[TBL] [Abstract][Full Text] [Related]
3. [Application of whole layer core biopsy of bladder wall to paravesical tumor].
Hoshi S; Orikasa S; Suzuki K; Kaneda T; Konda R; Maehara I; Kato H
Hinyokika Kiyo; 1994 Nov; 40(11):981-5. PubMed ID: 7832084
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy and bladder substitute for invasive bladder cancer: 20 years experience at Tohoku University.
Hoshi S; Orikasa S; Yoshikawa K; Sato K; Toyoda S; Saitoh S; Satoh M; Ohyama C; Namima T; Kawamura S; Suzuki K
Int J Urol; 1999 Feb; 6(2):68-74. PubMed ID: 10226810
[TBL] [Abstract][Full Text] [Related]
5. [Whole layer needle biopsy for evaluation of neoadjuvant therapy to invasive bladder cancer].
Hoshi S; Orikasa S; Yoshikawa K; Saitoh S; Ohyama C; Satoh M; Kawamura S; Suzuki K; Nakazumi H; Tochigi T
Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1649-55. PubMed ID: 1770703
[TBL] [Abstract][Full Text] [Related]
6. [Percutaneous transabdominal whole layer core needle biopsy for staging the urinary bladder cancer].
Ono K; Orikasa S; Hoshi S; Yoshikawa K; Tochigi T; Kanbe K
Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1681-8. PubMed ID: 1434272
[TBL] [Abstract][Full Text] [Related]
7. Accurate prediction of the amount of in situ tumor in palpable breast cancers by core needle biopsy: implications for neoadjuvant therapy.
El-Tamer M; Axiotis C; Kim E; Kim J; Wait R; Homel P; Braverman A
Ann Surg Oncol; 1999; 6(5):461-6. PubMed ID: 10458684
[TBL] [Abstract][Full Text] [Related]
8. The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Tang JH; An X; Lin X; Gao YH; Liu GC; Kong LH; Pan ZZ; Ding PR
Oncotarget; 2015 Oct; 6(32):33919-25. PubMed ID: 26416245
[TBL] [Abstract][Full Text] [Related]
9. Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma.
Numahata K; Satoh M; Handa K; Saito S; Ohyama C; Ito A; Takahashi T; Hoshi S; Orikasa S; Hakomori SI
Cancer; 2002 Feb; 94(3):673-85. PubMed ID: 11857299
[TBL] [Abstract][Full Text] [Related]
10. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.
D'Alfonso T; Liu YF; Monni S; Rosen PP; Shin SJ
Am J Surg Pathol; 2010 Apr; 34(4):575-81. PubMed ID: 20216378
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Daniel ES; Gibbs P; Guerrieri M; Faragher I
Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
[TBL] [Abstract][Full Text] [Related]
13. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
Rajan R; Poniecka A; Smith TL; Yang Y; Frye D; Pusztai L; Fiterman DJ; Gal-Gombos E; Whitman G; Rouzier R; Green M; Kuerer H; Buzdar AU; Hortobagyi GN; Symmans WF
Cancer; 2004 Apr; 100(7):1365-73. PubMed ID: 15042669
[TBL] [Abstract][Full Text] [Related]
14. Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer.
Okihara K; Kamoi K; Lane RB; Evans RB; Troncoso P; Babaian RJ
J Clin Ultrasound; 2002; 30(3):123-31. PubMed ID: 11948567
[TBL] [Abstract][Full Text] [Related]
15. Detectability of residual invasive bladder cancer in delayed
Higashiyama A; Komori T; Juri H; Inada Y; Azuma H; Narumi Y
Ann Nucl Med; 2018 Oct; 32(8):561-567. PubMed ID: 30014439
[TBL] [Abstract][Full Text] [Related]
16. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis.
Cha YJ; Ahn SG; Bae SJ; Yoon CI; Seo J; Jung WH; Son EJ; Jeong J
Breast Cancer Res Treat; 2018 Sep; 171(2):295-302. PubMed ID: 29869774
[TBL] [Abstract][Full Text] [Related]
18. The application of a novel integrated rigid and flexible Nephroscope in percutaneous nephrolithotomy for renal staghorn stones.
Yang H; Li J; Long G; Wang S
BMC Urol; 2017 Aug; 17(1):67. PubMed ID: 28836969
[TBL] [Abstract][Full Text] [Related]
19. The role of percutaneous biopsy in detection of pancreatic transplant rejection.
Lee BC; McGahan JP; Perez RV; Boone JM
Clin Transplant; 2000 Oct; 14(5):493-8. PubMed ID: 11048995
[TBL] [Abstract][Full Text] [Related]
20. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
